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Background: Sixty percent of infants with severe neonatal hypoxic-ischemic encephalopathy die, while 
most survivors have permanent disabilities. Treatment for neonatal hypoxic-ischemic encephalopathy 
is limited to therapeutic hypothermia, but it does not offer complete protection. Here, we investigated 
whether hypoxia-inducible factor (HIF) promotes cell survival and suggested neuroprotective strategies.
Purpose: HIF-1α deficient mice have increased brain injury after neonatal hypoxia-ischemia (HI), and the 
role of HIF-2α in HI is not well characterized. Copper-zinc superoxide dismutase (SOD)1 overexpression is 
not beneficial in neonatal HI. The expression of HIF-1α and HIF-2α was measured in SOD1 overexpressing 
mice and compared to wild-type littermates to see if alteration in expression explains this lack of benefit.
Methods: On postnatal day 9, C57Bl/6 mice were subjected to HI, and protein expression was measured 
by western blotting in the ipsilateral cortex of wild-type and SOD1 overexpressing mice to quantify HIF-1α 
and HIF-2α. Spectrin expression was also measured to characterize the mechanism of cell death.
Results: HIF-1α protein expression did not significantly change after HI injury in the SOD1 overexpressing 
or wild-type mouse cortex. However, HIF-2α protein expression increased 30 minutes after HI injury in the 
wild-type and SOD1 overexpressing mouse cortex and decreased to baseline value at 24 hours after HI 
injury. Spectrin 145/150 expression did not significantly change after HI injury in the SOD1 overexpressing 
or wild-type mouse cortex. However, spectrin 120 expression increased in both wild-type and SOD1 
overexpressing mouse at 4 hours after HI, which decreased by 24 hours, indicating a greater role of 
apoptotic cell death.
Conclusion: HIF-1α and HIF-2α may promote cell survival in neonatal HI in a cell-specific and regional 
fashion. Our findings suggest that early HIF-2α upregulation precedes apoptotic cell death and limits 
necrotic cell death. However, the influence of SOD was not clarified; it remains an intriguing factor in 
neonatal HI.
Key words: Brain injury, Cell death, Hypoxia-inducible factor, Hypoxic-ischemic encephalopathy, 
Superoxide dismutase
Key message 
Question: Can we treat neonatal hypoxic-ischemic encephalopathy?
Finding & Meaning: Both HIF-1α and HIF-2α may promote cell survival in animal model of neonatal 
hypoxia-ischemia. Developmental age, degree and type of injury are all factors in the expression and 
action of HIF-1α and HIF-2α. Early HIF-2α upregulation precedes apoptotic cell death and may limit 
necrotic cell death in animal model of neonatal hypoxia-ischemia.
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H2O2 to H2O and O2. However, SOD1 overexpression causes high 
H2O2 accumulation after HI in the neonatal brain, but not the 
adult.10) The accumulation of H2O2 and hydroxyl radical (OH-) causes 
nitric oxide radical production by NOS, lipid peroxi dation, protein 
oxidation, DNA damage, and finally neuronal death via necrosis or 
apoptosis.11) These data illustrate that neuro protective mechanisms 
of the developing neonatal brain are different from mature brain. 
We explored whether the expression of HIF-1α and HIF-2α were 
altered in SOD1 overexpressing mouse brain compared to wild-type 
littermates to explain this increased injury in neonatal brain.
Methods
This animal study was approved by the University of California 
San Francisco (UCSF) institutional animal care and use committee 
in accordance with National Institutes of Health (NIH) guidelines 
for the care and use of laboratory animals. C57Bl/6 mice and SOD1 
overexpressing littermates were subjected to the Vannucci model 
of neonatal HI.12-14) At postnatal day (P) 9, pups were anesthetized 
with isoflurane (3% isoflurane/balance oxygen), the left common 
carotid artery was dissected after a midline incision of the neck and 
the artery was ligated with electrical coagulation. Animals were 
allowed to recover for 1 hour with the dam and then exposed to 50 
minutes of hypoxia in a humidified chamber at 36.5°C with 10% 
oxygen/balance nitrogen. Sham-operated control animals received 
isoflurane anesthesia and exposure of the left common carotid artery 
without ligation or hypoxia. Pups were sacrificed at designated 
times after injury (30 minutes, 4 hours, or 24 hours) by decapitation 
Introduction
Neonatal hypoxic-ischemic encephalopathy causes death in 
twenty percent of affected infants, and 25% of survivors have per-
manent neurologic deficits such as developmental delay, cerebral 
palsy, cognitive dysfunction, hearing loss, and visual loss.1) Ten 
percent of moderate encephalopathy infants die and 30% of the 
survivors are handicapped; 60% of severe encephalopathy in fants 
die and most of the survivors have permanent disabilities.2) Treat-
ment of neonatal hypoxic-ischemic encephalopathy is limited to 
therapeutic hypothermia for those infants that qualify but does not 
offer complete protection. Several neuroprotective strategies have 
been suggested such as antioxidants or erythropoietin (EPO).3)
We have previously reported that hypoxia-inducible factor 
(HIF)-1α deficient mice have increased brain injury after neonatal 
hypoxia-ischemia (HI).4) HIF-1α is a nuclear protein induced by 
hypoxia, which acts as a transcription factor crucial for activation 
of many protective hypoxia-inducible genes such as erythropoietin, 
glucose transporters, inducible nitric oxide synthase (NOS), and 
vascular endothelial growth factor (VEGF).5,6) As a result, HIF-1α pro-
motes cell survival, and initiates neuroprotection, angiogenesis and 
subsequently, cell repair in neonatalHI.4,7)
We also have found that copper-zinc superoxide dismutase (SOD)1 
overexpression is not beneficial to the neonatal mouse brain with 
HI injury,8) unlike the adult brain with similar injury, in which SOD1 
overexpression was shown to be neuroprotective after cerebral 
ischemia.9) SOD1 is an endogenous antioxidant, which converts su-
peroxide anion (O2-) to hydrogen peroxide (H2O2) in neurons of the 
HI brain. Glutathione peroxidase (GPx) converts the accumulated 
Graphical abstract. Mechanisms of cell survival mediated by HIF
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after intraperitoneal injection of Euthasol. Brains cortices were 
dissected on a cold pad, placed in labeled prechilled microfuge tubes, 
flash frozen in methylbutane on dry ice, then stored at -80°C until 
use. Animals used in each group were 10, 11, 15, 13, 7, 13, 10, and 
13, in wild-type sham, SOD1 overexpressor sham, wild-type 30 
minutes, SOD1 overexpressor 30 minutes, wild-type 4 hours, SOD1 
overexpressor 4 hours, wild-type 24 hours, and SOD1 overexpressor 
24 hours after HI, respectively.
Western blot analysis was performed on ipsilateral cortex from 
wild-type and SOD1 overexpressing mice to quantify HIF-1α, HIF-
2α, spectrin 120 as a neuronal apoptosis marker, and spectrin 145/ 
150 as a neuronal necrosis marker at 30 minutes, 4 hours, and 24 
hours after HI injury.
Frozen cortices were homogenized and cytoplasmic and nuclear 
proteins were extracted with NE-PER (nuclear and cytoplasmic 
extraction reagents, Pierce, Rockford, IL, USA). Protein samples 
were prepared with 4X loading buffer and sample reducing agent 
(10X DTT) and 40-μg cytoplasmic protein or 20-μg nuclear protein 
underwent sodium dodecyl sulfate-polyacrylamide gel electropho-
resis at 150 V for 90 minutes. Proteins were transferred to polyvinyl 
difluoride membranes (Bio-Rad, Hercules, CA, USA) at 35 V 
overnight at 4°C as described by Chang et al.15) The membranes were 
blocked in 5% nonfat dry milk in Tris-buffered saline with Tween 
for at least 1 hour at room temperature with gentle shaking, then 
incubated with rabbit HIF-1α polyclonal antibody (1:1500; Novus 
Biologicals, Littleton, CO, USA), rabbit HIF-2α polyclonal antibody 
(1:500; Novus Biologicals), and rabbit histone monoclonal antibody 
(1: 8000; Cell Signaling Technology, Boston, MA, USA) or mouse 
spectrin monoclonal antibody (1:2000; Millipore, Temecula, CA, 
USA) and mouse beta-actin monoclonal antibody (1:2000; Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. 
Horseradish peroxidase-conjugated goat anti-rabbit antibodies 
(Santa Cruz Biotechnology) were used (1:2000 for HIF-1α and HIF-
2α, 1:4,000 for histone) as secondary antibodies. Bound antibodies 
were developed by en hanced chemiluminescence (ECL, Amersham 
Life Science, Arlington Heights, IL, USA) and exposed to film. Image 
J software (NIH, Bethesda, MD, USA) was used to measure the 
optical densities (OD) and areas of protein signal on after scanning.
Data were analyzed by nonparametric tests: the Mann-Whitney 
U test for 2 groups, and the analysis of variance with Kruskal-Wallis 
test for 3 or more groups. All data were analyzed using Prism 7 
(GraphPad Software, La Jolla, CA, USA). Data are given as mean± 
standard error, and P values <0.05 were considered significant.
Results
HIF-1α protein expression was not significantly altered in wild-
type or SOD1 overexpressing mouse cortex after HI injury (Fig. 
1A). However, HIF-2α protein expression increased in both wild-
type and SOD1 overexpressing mouse cortex, reaching peak levels 
of 7-fold for wild-type and 5-fold for SOD1 overexpressors at 30 
minutes after HI injury (Fig. 1B). The level of HIF-2α decreased at 4 
hours and  returned to baseline at 24 hours (Fig. 1B). There were no 
differences between SOD1 overexpressors and wild-type littermates 
by time point.
Spectrin 145/150 protein expression was not significantly altered 
in wild-type or SOD1 overexpressing mouse cortex after HI injury 
A B 
 30 Min         4 Hr            24 Hr  30 Min         4 Hr            24 Hr 
   
Fig. 1. Hypoxia-inducible factor (HIF)-1α and HIF-2α protein expression in the cortex of wild-type (WT) and 
copper-zinc superoxide dismutase (SOD)1 overexpressing mice. Protein expression in the cortex of WT 
and SOD1 overexpressing sham, 30 minutes, 4 hours, and 24 hours after hypoxia-ischemia (HI). Data are 
shown as optical densities (OD) normalized to WT sham. (A) HIF-1α was not significantly different after 
HI. (B) HIF-2α increased in the cortex of WT and SOD1 overexpressing mice at 30 minutes (*P<0.02 and 
P<0.03, respectively). HIF-2α decreased to baseline value by 24 hours in the cortex of WT (*P<0.01) and 
SOD1 overexpressing mice (**P<0.005).
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(Fig. 2A). However, spectrin 120 protein expression increased in 
both wild-type and SOD1 overexpressing mouse cortex, reaching 
peak levels of 3-fold for both wild-type and SOD1 overexpressors 4 
hours after HI injury (Fig. 2B).
Discussion
The developing neonatal brain, with a high rate of oxygen 
consumption, high concentrations of unsaturated fatty acids and 
relative lack of antioxidants is extremely vulnerable to oxida tive 
stress and exposure to exogenous free radicals and iron-mediated 
free radical injury.16) Antioxidants protect the brain by attacking 
various injury cascades. These are reactive oxygen species scavengers 
(melatonin, SOD, catalase), inhibitors of lipid peroxidation, EPO (as 
a free radical reducer), inhibitors of NOS and anti-inflammatories.17) 
The mechanism of neuroprotection by an iron chelator such as 
deferoxamine is that it activates and upregulates HIF-1α expression. 
The upregulated HIF-1α in turn activates various HIF-1α mediated 
genes, such as VEGF, which initiate a complicated neuroprotective 
cascade.18,19) HIF-1α, a subunit of HIF-1, is undetectable under 
normoxic conditions, which is induced by hypoxia and is promptly 
degraded under normoxia by the ubiquitin-proteasome pathway.20) 
Like HIF-1α, HIF-2α is induced by hypoxia. It is a less well-
characterized factor, but has been shown to be expressed much 
more in astrocytes than neurons21) and is the primary mediator of 
EPO expression induced by hypoxia, which is in turn protective to 
neurons,22) suggesting HIF-2α expression may play a bigger role in 
neuroprotection than HIF-1α. The actions of these 2 HIF isoforms 
are cell-specific, regional and developmentally regulated, being 
complementary rather than redundant.23)
Previously, in P7 mouse cortex, we have seen increased HIF-1α 
immediately after hypoxia alone and 24 hours after HI.4) Similarly, 
also in P7 mouse cortex, we saw increased HIF-1α immediately 
after hypoxia as well as at 4 hours and 24 hours after hypoxia.24) 
However, HIF-1α increased only immediately after HI, not at 4 hours 
or 24 hours after HI.24) On the contrary, HIF-1α decreased 4 hours 
after HI in P9 mouse cortex with no change in the hippocampus.25) 
We also measured HIF-2α in the latter study. HIF-2α did not change 
after HI in cortex, but declined in hippocampus at 30 minutes, 4 
hours, and 24 hours. These results corresponded with increased 
spectrin 145/150 at 4 hours and 24 hours in cortex, but not hippo-
campus, and with increased spectrin 120 at 24 hours in cortex and at 
4 hours in hippocampus,25) suggesting early and prolonged necrotic 
cell death with additional late stage apoptosis in the cortex, but early 
apoptotic cell death with a relative lack of necrotic cell death in the 
hippocampus. Thus, while we did not see significant changes in HIF-
1α in the present study, we did see a strong increase in HIF-2α in 
both wild-type and SOD1 overexpressing cortex after HI. This may 
be due, in part, to the above-mentioned cell-specific, regional and 
complementary actions of the HIF isoforms. We measured spectrin 
here also in order to determine if mechanism of cell death corre-
sponded to levels of HIF-1α or HIF-2α. Since spectrin 145/150 was 
not elevated, but spectrin 120 was (at 4 hours), this may indicate that 
apoptosis has a greater role than necrosis in genesis of the HI injury 
in the critical phase several hours after the insult. The expression of 
HIF-2α may play a bigger role in neonatal HI injury than HIF-1α. It 
is conceivable that HIF-2α stimulated production of factors (such as 
EPO) that protected neurons from necrotic injury while astrocytes 
(and perhaps neurons) underwent subsequent apoptotic death. While 
A B 
 30 Min           4 Hr            24 Hr 
 30 Min           4 Hr            24 Hr 
   
Fig. 2. Spectrin 145/150 and 120 expressions in the cortex of wild-type (WT) and copper-zinc superoxide 
dismutase (SOD)1 overexpressing mice. Protein expression in the cortex of WT and SOD1 overexpressing 
sham, 30 minutes, 4 hours, and 24 hours after hypoxia-ischemia (HI). Data are shown as optical densities 
(OD) normalized to WT sham. (A) Spectrin 145/150 expression was not significantly different after HI. (B) 
Spectrin 120 expression increased in the cortex of both WT and SOD1 overexpressing mice at 4 hours 
after HI (*P<0.03 for both).
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we did not analyze cell type, neurons and astrocytes may have 
different responses to injury that are reflected in gene expression at 
the time points studied.
The SOD1 overexpressing cortex behaved quite similarly to the 
wild-type cortex with regard to expression of HIF-1α, HIF-2α, spectrin 
145/150, and spectrin 120 at the time points after HI analyz ed here. 
Thus, alterations in expression of these factors do not explainthe 
increased injury we have previously seen in the SOD1 overexpressing 
brain compared to wild-type.
HIF-2α activates transcription of mitochondrial manganese 
SOD (SOD2).26) The early increase in HIF-2α seen in both wild-type 
and SOD1 overexpressing cortex may indicate additional SOD 
production; a factor that warrants further study.
The activation of HIF-1α and the consequence of the activation of 
its target genes are suggested to be necessary for protection in neo-
natal HI.4,11) During neonatal brain injury, excitotoxicity (excessive 
activation of glutamate neurotransmission, oxidative stress, and 
inflammation) contributes to cell death either by apoptosis or necro-
sis. Apoptosis, or programmed cell death, seems to play a more 
important role than necrosis during HI injury.16)
The role of HIF-2α in neonatal HI brain is relatively unexplored. 
HIF-2α is activated by hypoxia stimulated mitogen-activated pro­
tein kinase (MAPK)/ERK signaling pathway, leading to the increased 
transcription of various proliferation factors. HIF-2α directly binds 
the MAPK3 promoter and activates its function through the inter-
action of the transcription factor and its regulated genes.27) In 
cardiac myocytes in adult mice, myocyte-specific HIF-2α induced 
the epithelial growth factor amphiregulin (AREG), activating AREG 
signaling, and finally protecting the myocardium from myocardial 
ischemia-reperfusion injury.28) In the carotid body, intermittent 
hypoxia leads to increased expression of HIF-1α and decreased levels 
of HIF-2α along with decreased SOD2 expression.29) In mesenchymal 
stem cells, HIF-2α maintained significant long-term effects, and was 
more stable in hypoxic conditions than normoxic.27) In the brain, 
HIF-2α is considered to be astrocyte specific, and astrocytes are im-
portant for the clearance of H2O2, resulting in neuroprotection. Wild-
type brain with decreased expression of HIF-2α had more severe 
brain injury compared to GPx overexpressing brain with higher HIF-
2α. This may be a reflection of a neuroprotective effect of HIF-2α 
associated with SOD2 generated H2O2 clearing.25)
Increased HIF-1α after HI is reported in many cases,4,24,30) however, 
HIF-1α is not changed or rather decreased in some cases as previous-
ly mentioned.25) The expressions of HIF-1α are different according to 
the time after HI, cell types (neurons vs. astrocyte), region (cortex vs. 
hippocampus), or developmental age (P7 vs. P9). So, these different 
experimental conditions partially account for these different results.
There are several limitations in this study. First, the grade of brain 
injury with histological analysis was not checked in the present 
study. Though we have shown injury severity with HI brain injury 
scores twice in the past,24) the experimental conditions such as de-
velopmental age (P7 vs. P9) were different from the previous study. 
It is not technically feasible to do histology and protein ex pression 
in the same sample. Also, spectrin is an assessment of injury which 
is not quite comparable to histology. Further work is needed to 
clarify the grade of brain injury. Second, SOD1 expression of SOD 
overexpressors was not checked. However, as these mice are well-
characterized, and we have done SOD activity in the past,31) we 
didn’t check SOD1 expression on the transgenics in the present 
study. Third, we could not find difference of protein expressions 
after HI between wild-type and SOD1 overexpressing mouse. Some 
of this might be due to small number of mice underwent this experi-
ment.
In summary, we propose that both HIF-1α and HIF-2α may 
promote cell survival in neonatal HI, but in a cell-specific and re-
gional fashion. We also suggest that early HIF-2α upregulation 
precedes apoptotic cell death and may limit necrotic cell death. 
Developmental age, degree and type of injury are all factors in the 
expression and action of HIF-1α and HIF-2α. The influence of SOD 
was not clarified and remains an intriguing factor in neonatal HI. 
Further work is needed to clarify the roles of HIF-1α and HIF-2α in 
neonatal brain injury.
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